UniSuper Management’s AbbVie ABBV Stock Holding History

UniSuper Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$61.1M	Buy	281,144 +27,941	+11%	+$6.2M	0.4%	54
2025 Q4	$57.9M	Buy	253,203 +1,809	+0.7%	+$412K	0.35%	61
2025 Q3	$58.2M	Buy	251,394 +21,547	+9%	+$4.39M	0.36%	58
2025 Q2	$42.7M	Sell	229,847 -2,761	-1%	-$513K	0.29%	77
2025 Q1	$48.7M	Buy	232,608 +133,172	+134%	+$25.9M	0.36%	56
2024 Q4	$17.7M	Buy	99,436 +15,690	+19%	+$2.88M	0.13%	118
2024 Q3	$16.5M	Buy	83,746 +3,543	+4%	+$661K	0.12%	124
2024 Q2	$13.8M	Buy	80,203 +50,273	+168%	+$8.33M	0.11%	126
2024 Q1	$5.45M	Sell	29,930 -127,666	-81%	-$22M	0.05%	171
2023 Q4	$24.4M	Sell	157,596 -16,284	-9%	-$2.37M	0.27%	87
2023 Q3	$25.9M	Buy	173,880 +12,089	+7%	+$1.77M	0.32%	77
2023 Q2	$21.8M	Buy	+161,791	New	+$23.7M	0.25%	86

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

UniSuper Management's ABBV Position: Q1 2026 in Review

UniSuper Management increased its AbbVie (ABBV) stake by 11% in Q1 2026, buying an estimated $6.2M and bringing the position to 281,144 shares worth $61.1M. The position accounts for 0.4% of the portfolio, ranked #54.

UniSuper Management first reported a position in ABBV in Q2 2023 and has held it in 12 quarters since. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

UniSuper Management held 281,144 shares of AbbVie worth $61.1M as of Q1 2026.
UniSuper Management bought 27,941 AbbVie shares in Q1 2026, an estimated $6.2M.
AbbVie made up 0.4% of UniSuper Management's portfolio in Q1 2026, its #54 holding.
UniSuper Management first reported a position in AbbVie in Q2 2023 and has held it in 12 quarters since.
4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on UniSuper Management's 13F filing for Q1 2026, filed 11 May 2026.